Italo Biaggioni, a respected Vanderbilt researcher in the field, has co-authored 100’s of studies on dysautonomia. He was an impressive speaker, at ease and relaxed in front of the room. I felt like I was sitting in his living room. He noted that the...
Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?Jo Nijs,Marco L. Loggia,Andrea Polli,Maarten Moens,Eva Huysmans,Lisa Goudman, Expert Opinion on Therapeutic Targets Volume 21, 2017...
It wasn’t supposed to go this way. Daiichi Sankyo bet big, big money that it’s safer, more effective version of Lyrica (pregabalin) called mirogabalin was going to be the next big thing in fibromaylgia (FM). It was so confident that it embarked on a...
